Washington Regional Medical Center Selects Global Med's SafeTrace Tx(R) Transfusion Management System
November 17 2003 - 9:30AM
PR Newswire (US)
Washington Regional Medical Center Selects Global Med's SafeTrace
Tx(R) Transfusion Management System DENVER, Nov. 17
/PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a
division of Global Med Technologies(R), Inc. (BULLETIN BOARD: GLOB)
("Global Med" or the "Company"), today announced the signing of an
agreement with Washington Regional Medical Center in Fayetteville,
Arkansas for SafeTrace Tx(R) Advanced Transfusion Management
system. Terms of the agreement were not disclosed. "SafeTrace Tx
was selected to manage our transfusion service because of its
comprehensive safety features and its extensive management of
patients and blood products," said Becky Magee, Vice President and
CIO of Washington Regional Medical Center. Ms. Magee added,
"SafeTrace Tx will help us deliver high quality services and blood
products to our patients with greater efficiency." About Washington
Regional Washington Regional, located in Fayetteville, Arkansas, is
a locally owned and governed healthcare system whose services now
reach 300,000 people in Washington, Benton, Madison and Carroll
counties in Northwest Arkansas. Washington Regional Medical Center,
established in 1950, is the flagship facility of Washington
Regional. Information about Washington Regional is available on its
website at http://www.wregional.com/ . About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an e-Health
medical information technology company providing information
management software products and services to the healthcare
industry. Its Wyndgate Technologies division is a leading supplier
of information management systems to U.S. blood centers and
transfusion services. Current clients of Wyndgate's products and
services manage more than 3 million units of blood, or over 22% of
the U.S. blood supply, each year. Together, the SafeTrace Tx*
Advanced Transfusion Management System and the SafeTrace(R) Donor
Management System provide Vein- to-Vein(R) tracking from donor
collection to patient transfusion. For more information about
Global Med's products and services, call 800-WYNDGATE or visit
http://www.globalmedtech.com/ , http://www.peoplemed.com/ and
http://www.wyndgate.com/ . Press Inquiries: Investor Inquiries:
Patti Larson Tom Marcinek Senior Director of Marketing Development
President and COO 916-404-8492 916-404-8413 This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release. *Patent Pending DATASOURCE:
Global Med Technologies, Inc. CONTACT: Press Inquiries, Patti
Larson, Senior Director of Marketing Development, +1-916-404-8492,
, or Investor Inquiries, Tom Marcinek, President and COO,
+1-916-404-8413, , both for Global Med Technologies, Inc. Web site:
http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web
site: http://www.wregional.com/ Web site:
http://www.globalmedtech.com/
Copyright